Literature DB >> 10981072

Recent outcome trials of newer antihypertensives.

S Bakir1, S Oparil.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10981072     DOI： 10.1007/s11906-999-0027-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  8 in total

1.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors:  L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

2.  Isolated systolic hypertension in the elderly.

Authors:  J Staessen; A Amery; R Fagard
Journal:  J Hypertens       Date:  1990-05       Impact factor: 4.844

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; W H Birkenhäger; C J Bulpitt; P W de Leeuw; A E Fletcher; M R Babarskiene; F Forette; J Kocemba; T Laks; G Leonetti; C Nachev; J C Petrie; J Tuomilehto; H Vanhanen; J Webster; Y Yodfat; A Zanchetti
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

8.  Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization.

Authors:  A Amery; W Birkenhäger; C J Bulpitt; D Clément; P De Leeuw; C T Dollery; R Fagard; A Fletcher; F Forette; G Leonetti
Journal:  Aging (Milano)       Date:  1991-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.